SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14657598
Source:
http://linkedlifedata.com/resource/pubmed/id/14657598
Search
Subject
(
53
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0039736
,
umls-concept:C0087111
,
umls-concept:C0205179
,
umls-concept:C2239176
pubmed:issue
3
pubmed:dateCreated
2003-12-5
pubmed:abstractText
To analyze the efficacy of oral thalidomide in the treatment of advanced hepatocellular carcinoma (HCC).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0135054
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Fetoproteins
pubmed:status
MEDLINE
pubmed:issn
0030-2414
pubmed:author
pubmed-author:ChenChiung-NienCN
,
pubmed-author:ChenLi-TzongLT
,
pubmed-author:ChengAnn-LiiAL
,
pubmed-author:ChungN PNP
,
pubmed-author:LaiMing-YangMY
,
pubmed-author:LeePo-HuangPH
,
pubmed-author:WuChen-YaoCY
,
pubmed-author:YangPei-MingPM
pubmed:copyrightInfo
Copyright 2003 S. Karger AG, Basel
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
242-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:14657598-Administration, Oral
,
pubmed-meshheading:14657598-Adult
,
pubmed-meshheading:14657598-Aged
,
pubmed-meshheading:14657598-Angiogenesis Inhibitors
,
pubmed-meshheading:14657598-Carcinoma, Hepatocellular
,
pubmed-meshheading:14657598-Dose-Response Relationship, Drug
,
pubmed-meshheading:14657598-Drug Administration Schedule
,
pubmed-meshheading:14657598-Female
,
pubmed-meshheading:14657598-Humans
,
pubmed-meshheading:14657598-Liver Neoplasms
,
pubmed-meshheading:14657598-Male
,
pubmed-meshheading:14657598-Middle Aged
,
pubmed-meshheading:14657598-Neoplasm Staging
,
pubmed-meshheading:14657598-Survival Rate
,
pubmed-meshheading:14657598-Thalidomide
,
pubmed-meshheading:14657598-Treatment Outcome
,
pubmed-meshheading:14657598-alpha-Fetoproteins
pubmed:year
2003
pubmed:articleTitle
Low-dose thalidomide treatment for advanced hepatocellular carcinoma.
pubmed:affiliation
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't